Experiment 379241
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | INTRAGASTRIC |
| Organism | Cryptolepis sanguinolenta (ASCLEPIADACEAE) |
| Citation | LUO,J: FORT,DM: CARLSON,TJ: NOAMESI,BK: NII-AMON-KOTEI,D: KING,SR: TSAI,J: QUAN,J: HOBENSACK,C: LAPRESCA,P: WALDECK,N: MENDEZ,CD: JOLAND,SD: BIERER,DE: REAVEN,GM:. (1998). CRYPTOLEPIS SANGUINOLENTA: AN ETHNOBOTANICAL APPROACH TO DRUG DISCOVERY AND THE ISOLATION OF A POTENTIALLY USEFUL NEW ANTHYPERGLYCAEMIC AGENT.. 15(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | VS.DIABETIC ANIMALS. |
| Dose amount | 10.0 MG |
| Number | 4 |
| Qualitative result | ACTIVE |
| Animal | MOUSE |
| Per unit | KG |
| Dose expression | DOSE |
| Gender | MALE |